Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants ; day:13 ; month:9 ; year:2023 ; pages:1-6
Journal of thrombosis and thrombolysis ; (13.9.2023), 1-6
- Urheber
-
Lilja, Johan
Själander, Anders
Själander, Sara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-023-02890-y
- URN
-
urn:nbn:de:101:1-2023112713403837064777
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lilja, Johan
- Själander, Anders
- Själander, Sara
- SpringerLink (Online service)
Ähnliche Objekte (12)
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort